CBP-4888

N/A

Report date: 2026/05/09 20:00:18
NME

Base Information

Drug NameCBP-4888
Drug Alias NameCBP-4888
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA
Mechanisms of ActionVascular endothelial growth factor receptor 1 antagonists
TargetsVascular endothelial growth factor receptor 1
Therapy Area/IndicationsPre-EclampsiaEclampsia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesAustralia
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesComanche Biopharma Corp
Inactive CompaniesN/A
Active IndicationsPre-EclampsiaEclampsia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A